SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057457
Filing Date
2024-05-10
Accepted
2024-05-10 07:30:31
Documents
49
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q wve-20240331.htm   iXBRL 10-Q 1033579
2 EX-31.1 wve-ex31_1.htm EX-31.1 14690
3 EX-31.2 wve-ex31_2.htm EX-31.2 14832
4 EX-32 wve-ex32.htm EX-32 10294
5 GRAPHIC img57341224_0.jpg GRAPHIC 50036
6 GRAPHIC img57341224_1.jpg GRAPHIC 77389
  Complete submission text file 0000950170-24-057457.txt   4395034

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT wve-20240331.xsd EX-101.SCH 746137
53 EXTRACTED XBRL INSTANCE DOCUMENT wve-20240331_htm.xml XML 370116
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 24932895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)